Feed aggregator

Q3 2019 results

Deutsche Bank - Thu, 10/31/2019 - 14:36
Q3 2019 results with Investor and Analyst Conference Call
Categories: XEX companies

Q2 2019 results

Deutsche Bank - Thu, 07/25/2019 - 15:33
Q2 2019 results with Investor and Analyst Conference Call
Categories: XEX companies

Annual General Meeting

Deutsche Bank - Thu, 05/23/2019 - 15:32
Categories: XEX companies

Q1 2019 Results

Deutsche Bank - Fri, 04/26/2019 - 11:37
Q1 2019 Results with Investor and Analyst Conference Call
Categories: XEX companies

Stocks Pause Ahead of Tech Earnings

NASDAQ Fintech - 4 hours 16 min ago
When you ve soared approximately 25 in four months to new highs it s understandable to take a bit of a breather That s the route the S amp P has taken from the Christmas Eve lows through yesterday s closing high to today s slight pullback In addition to the fatigue though the market
Categories: Nasdaq News english

Philips introduces VitalMinds, new non-pharmacological approach for preventing delirium in the ICU

Philips - 6 hours 36 min ago
Philips launches VitalMinds, new non-pharmacological approach to prevent delirium in ICU patients, now with CE Mark. Unique VitalSky light and sound management and circadian-effective light therapy is now commercially available in Germany, Austria, Switzerland, Finland and Sweden, with market launches planned in other European countries over the next two years.
Categories: XEX companies

The question I ask myself every day…

Philips - 6 hours 48 min ago
How can healthcare providers embrace the industry’s Quadruple Aim through continuous innovation? Philips’ Bert van Meurs discusses the role of image-guided therapy in this mix.
Categories: XEX companies

End of discussions with Commerzbank: message from Christian Sewing to Deutsche Bank staff

Deutsche Bank - 7 hours 24 min ago

Dear Colleagues,

A few weeks ago we started talks with Commerzbank to consider a combination of our two banks. We have consistently said that we want to play an active role in the consolidation of the European banking sector. For that reason, we decided to evaluate this option thoroughly.

Our discussions with Commerzbank were very intense and took place in a constructive and mutually respectful atmosphere. However, we have now decided not to pursue this possibility further. How did we reach this conclusion?

We were always clear that we needed to be conv

Categories: XEX companies

Deutsche Bank and Commerzbank discontinue discussions

Deutsche Bank - 8 hours 1 min ago

Frankfurt am Main, April 25, 2019 – After careful analysis, the Management Board of Deutsche Bank has concluded today that a combination with Commerzbank would not have created sufficient benefits to offset the additional execution risks, restructuring costs and capital requirements associated with such a large-scale integration. As a result, the two banks have decided to discontinue discussions.

Deutsche Bank will continue to review all alternatives to improve long-term profitability and shareholder returns.

For the first quarter of 2019, Deutsche Bank expects to report

Categories: XEX companies

Deutsche Bank and Commerzbank discontinue discussions

Deutsche Bank - 8 hours 5 min ago

Deutsche Bank (XETRA: DBKGn.DE / NYSE: DB) and Commerzbank decided today to discontinue their discussions concerning a combination of their businesses. After careful analysis it became apparent that such a combination would not be in the interests of either bank’s shareholders or other stakeholders.

“It made sense to evaluate this option for domestic consolidation in Germany. However, we were always clear: we needed to be convinced that any potential combination would generate higher and more sustainable returns for shareholders and allow us to enhance our value propositi

Categories: XEX companies

Validea Warren Buffett Strategy Daily Upgrade Report - 4/25/2019

NASDAQ Fintech - 10 hours 25 min ago
The following are today s upgrades for Validea s Patient Investor model based on the published strategy of Warren Buffett This strategy seeks out firms with long term predictable profitability and low debt that trade at reasonable valuations The following are today s upgrades
Categories: Nasdaq News english

Validea Peter Lynch Strategy Daily Upgrade Report - 4/25/2019

NASDAQ Fintech - 10 hours 25 min ago
The following are today s upgrades for Validea s P E Growth Investor model based on the published strategy of Peter Lynch This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets The following are today s upgrades
Categories: Nasdaq News english

Validea Motley Fool Strategy Daily Upgrade Report - 4/25/2019

NASDAQ Fintech - 10 hours 25 min ago
The following are today s upgrades for Validea s Small Cap Growth Investor model based on the published strategy of Motley Fool This strategy looks for small cap growth stocks with solid fundamentals and strong price performance The following are today s upgrades for Validea sSmall Cap
Categories: Nasdaq News english

Validea Martin Zweig Strategy Daily Upgrade Report - 4/25/2019

NASDAQ Fintech - 10 hours 26 min ago
The following are today s upgrades for Validea s Growth Investor model based on the published strategy of Martin Zweig This strategy looks for growth stocks with persistent accelerating earnings and sales growth reasonable valuations and low debt The following are today s upgrades
Categories: Nasdaq News english

Validea Kenneth Fisher Strategy Daily Upgrade Report - 4/25/2019

NASDAQ Fintech - 10 hours 26 min ago
The following are today s upgrades for Validea s Price Sales Investor model based on the published strategy of Kenneth Fisher This value strategy rewards stocks with low P S ratios long term profit growth strong free cash flow and consistent profit margins The following are today s
Categories: Nasdaq News english

Validea Joseph Piotroski Strategy Daily Upgrade Report - 4/25/2019

NASDAQ Fintech - 10 hours 26 min ago
The following are today s upgrades for Validea s Book Market Investor model based on the published strategy of Joseph Piotroski This value quant strategy screens for high book to market stocks and then separates out financially sound firms by looking at a host of improving
Categories: Nasdaq News english

Validea John Neff Strategy Daily Upgrade Report - 4/25/2019

NASDAQ Fintech - 10 hours 26 min ago
The following are today s upgrades for Validea s Low PE Investor model based on the published strategy of John Neff This strategy looks for firms with persisten t earnings growth that trade at a discount relative to their earnings growth and dividend yield The following are today s
Categories: Nasdaq News english

Validea Joel Greenblatt Strategy Daily Upgrade Report - 4/25/2019

NASDAQ Fintech - 10 hours 26 min ago
The following are today s upgrades for Validea s Earnings Yield Investor model based on the published strategy of Joel Greenblatt This value model looks for companies with high return on capital and earnings yields The following are today s upgrades for Validea sEarnings Yield Investor
Categories: Nasdaq News english

Validea David Dreman Strategy Daily Upgrade Report - 4/25/2019

NASDAQ Fintech - 10 hours 26 min ago
The following are today s upgrades for Validea s Contrarian Investor model based on the published strategy of David Dreman This contrarian strategy finds the most unpopular mid and large cap stocks in the market and looks for improving fundamentals The following are today s upgrades
Categories: Nasdaq News english

Philips launches IntelliSpace Radiation Oncology to accelerate time from patient referral to the start of treatment

Philips - 10 hours 36 min ago
Philips IntelliSpace Radiation Oncology is an intelligent patient management solution to manage complexity, improve efficiency and enable operational excellence in radiotherapy departments. Unveiled at ESTRO 38, the solution provides a harmonized way of working, integrating applications and automating workflow.
Categories: XEX companies

Pages

Subscribe to XEX aggregator